Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

The Macroimportance of the Pulmonary Immune Microenvironment
Lee, Nancy A., Lee, James J.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 21 | Issue: 3 | Pages: 298-302

10.1165/ajrcmb.21.3.f165 | PMID 10460746 Get It

In Vitro Transport of Active α1-Antitrypsin to the Apical Surface of Epithelia by Targeting the Polymeric Immunoglobulin Receptor
Eckman, Elizabeth A. , Mallender, William D. , Szegletes, T., Silski, Catherine L., Schreiber, John R. , Ferkol, Thomas W. , Davis, Pamela B.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 21 | Issue: 2 | Pages: 246-252

10.1165/ajrcmb.21.2.3687 | PMID 10423408 Get It

Abstract In cystic fibrosis (CF), the intense host inflammatory response to chronic infection largely accounts for the progressive pulmonary disease, and ultimately death. Neutrophils are the prominent inflammatory cells in the lungs of patients with CF, and large amounts of neutrophil elastase (NE) are released during phagocytosis. Besides having direct effects on structural elastin, NE stimulates the release of proinflammatory mediators from the respiratory epithelium and is a potent secretogogue. Therapeutic use of elastase inhibitors in CF has been complicated by difficulties in delivery to the critical site in the airway—the surface of the epithelium. We describe a unique strategy to protect the respiratory epithelial cell surface directly by capitalizing on the nondegradative transcytotic pathway of the polymeric immunoglobulin receptor (pIgR). A recombinant fusion protein was constructed consisting of an antihuman pIgR single-chain Fv (scFv) antibody linked to human α1-antitrypsin (A1AT), an inhibitor of NE. The recombinant scFv-A1AT fusion protein bound specifically to the pIgR on the basolateral surface of an epithelial cell monolayer, and was transported and released into the apical medium where the A1AT domain was capable of forming an inactivation complex with NE. Thus, A1AT linked to an antihuman pIgR scFv was delivered in receptor-specific fashion from the basolateral to apical surface and was released as an active antiprotease, indicating that it is feasible to deliver therapeutic proteins to the apical surface of epithelia by targeting the pIgR.
Stimulation of Neutrophil Interleukin-8 Production by Eosinophil Granule Major Basic Protein
Page, Scott M., Gleich, Gerald J. , Roebuck, Kenneth A., Thomas, Larry L.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 21 | Issue: 2 | Pages: 230-237

10.1165/ajrcmb.21.2.3647 | PMID 10423406 Get It

Abstract We evaluated the ability of eosinophil granule major basic protein (MBP) to stimulate interleukin (IL)-8 production by neutrophils. MBP over the concentration range of 0.1 to 10 μM stimulated the release of up to approximately 8 ng/ml IL-8. Incubation with 2 μM MBP showed that, after a 1 h lag, the level of IL-8 release increased with time for approximately 10 h. At the 2 μM concentration, eosinophil cationic protein, eosinophil-derived neurotoxin, and eosinophil peroxidase did not stimulate significant levels of IL-8 production. MBP stimulated 2-fold increases in IL-8 messenger RNA (mRNA) after 1 and 3 h of incubation, which were blocked by pretreatment with actinomycin D. However, stimulation with MBP did not produce an increase in the binding activity of nuclear factor (NF)-κB or activator protein-1. No NF–IL-6 binding activity was detected in the same nuclear extracts. In addition, stimulation with MBP prolonged the stability of IL-8 mRNA. MBP also induced transient increases in mRNA for macrophage inflammatory protein (MIP)-1α and MIP-1β, but did not stimulate the release of either chemokine. These findings indicate that MBP is selective among the eosinophil granule proteins as a stimulus for neutrophil IL-8 release and, further, that stimulation of neutrophil IL-8 release by MBP involves both transcriptional and posttranscriptional regulation. We postulate that MBP-induced release of IL-8 by neutrophils may contribute to the pathophysiology of acute asthma and other inflammatory lung diseases.
Role of Arachidonyl Triglycerides within Lipid Bodies in Eicosanoid Formation by Human Polymorphonuclear Cells
Johnson, Margaret M. , Vaughn, Ben , Triggiani, Massimo , Swan, Dennis D., Fonteh, Alfred N. , Chilton, Floyd H. , Fonteh, Alfred

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 21 | Issue: 2 | Pages: 253-258

10.1165/ajrcmb.21.2.3489 | PMID 10423409 Get It

Abstract Increasing evidence suggests that the subcellular and glycerolipid localization of esterified arachidonic acid (AA) is a key factor in regulating its availability to lipases. The goal of the current study was to determine the potential of AA stored in triglycerides (TG) to serve as a substrate for lipases and 5-lipoxygenase during neutrophil (polymorphonuclear leukocytes, PMN) activation. PMN containing high concentrations of AA in TG were generated by culturing PMN in vitro with high concentrations of exogenous AA (eAA) for 12 h. Cellular AA increased 2- and 4-fold in PMNs incubated with 5 and 20 μM AA, respectively, and this increase was almost exclusively observed in neutral lipids (NL). Further analysis revealed that 88% of the AA in the NL fraction was associated with TG. Subsequent experiments were designed to determine whether this AA in TG could be mobilized and metabolized to eicosanoids during cell activation. TG pools of AA were increased as previously described and then PMN were stimulated with ionophore, A23187. In contrast to the 43-fold increase in TG AA after eAA loading (20 μM), free AA increased by only 1.9-fold after cell stimulation. Similarly, leukotriene (LT)B4 production increased only 2-fold after loading TG with large quantities of AA. The magnitude of increase in free AA released and in LTB4 formation was similar to the magnitude of increase in AA mass in phospholipase (PL), suggesting that PL, and not TG, served as the source of released AA and subsequent product generation. To confirm that AA in TG did not serve as a source for eicosanoid production, cellular pools of AA were differentially labeled with [14C]AA and [3H]AA, and the [3H]AA–to–[14C]AA ratio of LTB4 and 20-hydroxyl LTB4 produced during cell stimulation was measured. The [3H]AA/[14C]AA ratios of LTs were markedly different from the ratios in TG, thus providing further evidence that AA pools in TG are not a major source of AA for LT generation.
ATP Modulates Anti-IgE–Induced Release of Histamine from Human Lung Mast Cells
Schulman, Edward S. , Glaum, Mark C., Post, Tom, Wang, Yihe , Raible, Donald G., Mohanty, Joy G., Butterfield, Joseph H. , Pelleg, Amir

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 20 | Issue: 3 | Pages: 530-537

10.1165/ajrcmb.20.3.3387 | PMID 10030852 Get It

Abstract Adenosine 5′-triphosphate (ATP) is released from the cytoplasm under physiologic and pathophysiologic conditions and enters the extracellular space, where it acts on a group of recently cloned cell-surface receptors termed P2-purinoceptors (subtypes P2X and P2Y). We examined the effects of extracellular ATP, uridine triphosphate (UTP), the stable ATP analogues α,βmethylene-ATP (α,βmATP), β,γmethylene-ATP (β,γmATP), and 2-methylthio-ATP (2mSATP), and adenosine (10−6–10−3 M) on histamine release from human lung mast cells (HLMC) induced by anti-IgE and the calcium ionophore A23187. None of the nucleotides or adenosine directly induced histamine release. Adenosine exhibited a bimodal effect, enhancing histamine release at 10−6 to 10−4 M (P > 0.05, NS) and inhibiting it at 10−3 M (P < 0.05). ATP (10−4 M) enhanced anti-IgE–induced histamine release (10.9 ± 2.7% to 19.2 ± 2.9%, n = 20, P < 0.01), but not ionophore A23187-induced histamine release (n = 10). The adenine nucleotides consistently enhanced anti-IgE–induced histamine release; the rank order for this action was: ATP > 2mSATP > α,βmATP > β,γmATP, suggesting mediation by a P2Y-purinoceptor subtype. The selective P2X purinoceptor antagonist pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid failed to influence the effect of ATP, further supporting P2Y-purinoceptor mediation of anti-IgE–induced histamine release. UTP, an agonist at P2Y-purinoceptors, also significantly enhanced anti-IgE–induced histamine release. Application of the reverse transcription–polymerase chain reaction indicated that HLMC constitutively express the messenger RNAs encoding the P2Y1- and P2Y2-purinoceptor subtypes, and not that encoding the P2X7-purinoceptor (i.e., P2Z), a subtype implicated in ATP-induced histamine release in rodent peritoneal mast cells. The data produced in the study suggest that ATP plays an important modulatory role in histamine release from HLMC, and that it may therefore be mechanistically involved in human allergic/asthmatic reactions.
Hyaluronan: Is Bigger Better?
Camenisch, Todd D. , McDonald, John A.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 23 | Issue: 4 | Pages: 431-433

10.1165/ajrcmb.23.4.f201 | PMID 11017905 Get It

Phosphatidylinositol Kinase Regulation of Airway Smooth Muscle Cell Proliferation
Thomas, Charles F., Limper, Andrew H.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 23 | Issue: 4 | Pages: 429-430

10.1165/ajrcmb.23.4.f200 | PMID 11017904 Get It

Pneumocystis carinii Uses a Functional Cdc13 B-Type Cyclin Complex during Its Life Cycle
Thomas, Charles F., Mubarak, Kamal K., Leof, Edward B. , Kottom, Theodore J. , Limper, Andrew H.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 22 | Issue: 6 | Pages: 722-731

10.1165/ajrcmb.22.6.3838 | PMID 10837370 Get It

Abstract Pneumocystis carinii causes severe pneumonia in immunocompromised patients. Recent studies indicate that P. carinii uses a Cdc2 cyclin-dependent kinase to control its proliferation. To further study the regulation of the life cycle of P. carinii, we characterized the P. carinii B-type cyclin termed Cdc13, whose binding to Cdc2 is necessary for kinase activity. Antibodies to B-type cyclins (Cdc13) specifically immunoprecipitated Cdc2/Cdc13 complexes with associated kinase activity from P. carinii extracts. To clone P. carinii cdc13, degenerate polymerase chain reaction was undertaken using primers generated from amino-acid motifs conserved in fungal Cdc13 proteins. This amplicon was used to obtain full-length genomic and complementary DNA (cDNA) clones. A specific synthetic peptide antibody generated to P. carinii Cdc13 further demonstrated differential Cdc2/Cdc13 activity over the life cycle of P. carinii, with greater activity in cysts compared with trophic forms of the organism. Finally, P. carinii cdc13 cDNA was used to rescue mutant Schizosaccharomyces pombe strains containing temperature-sensitive deficiencies of endogenous Cdc13 activity, thus verifying function of the P. carinii Cdc13 protein. Therefore, P. carinii contains a Cdc13 cyclin, which is variably active over its life cycle and which promotes fungal proliferation.
Vitronectin and Fibronectin Function as Glucan Binding Proteins Augmenting Macrophage Responses to Pneumocystis carinii
Vassallo, Robert , Standing, Joseph E., Kottom, Theodore J. , Limper, Andrew H. , Vassallo, Robert

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 25 | Issue: 2 | Pages: 203-211

10.1165/ajrcmb.25.2.4427 | PMID 11509330 Get It

Abstract β -glucans represent major structural components of fungal cell walls. We recently reported that Pneumocystis carinii β -glucans stimulate alveolar macrophages to release proinflammatory cytokines. Macrophage activation by β -glucan is augmented by serum, implying the presence of circulating factors that interact with β -glucans and enhance their ability to stimulate macrophages. Using β -glucan–enriched cell wall fractions from P. carinii and Saccharomyces cerevisiae, two prominent proteins were precipitated from serum and demonstrated to be vitronectin (VN) and fibronectin (FN) by immune analysis. Preincubation of β -glucan with VN or FN enhanced macrophage activation in response to this cell wall component. Because VN and FN accumulate in the lungs during P. carinii pneumonia, we further investigated hepatic and pulmonary expression of VN and FN messenger RNA during infection. P. carinii pneumonia in rodents is associated with increased hepatic expression of VN and FN as well as increased local expression of FN in the lung. Because interleukin (IL)-6 represents the major regulator of VN and FN expression during inflammatory conditions, we measured macrophage IL-6 release in response to stimulation with P. carinii β -glucan. Stimulation of macrophages with P. carinii β -glucan induced significant release of IL-6. Elevated concentrations of IL-6 were noted in the blood of infected animals compared with uninfected control animals. These studies indicate that VN and FN bind to β -glucan components of P. carinii and augment macrophage inflammatory responses. P. carinii cell wall β -glucan stimulates secretion of IL-6 by macrophages, thereby enhancing hepatic synthesis of both VN and FN, and lung synthesis of FN during pneumonia.
Carbohydrate Recognition Domain of Surfactant Protein D Mediates Interactions with Pneumocystis carinii Glycoprotein A
Vuk-Pavlović, Zvezdana, Standing, Joseph E., Crouch, Erika C., Limper, Andrew H.

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 24 | Issue: 4 | Pages: 475-484

10.1165/ajrcmb.24.4.3504 | PMID 11306442 Get It

Abstract Pneumocystis carinii continues to cause severe pneumonia in immunocompromised patients. Surfactant protein D (SP-D), a lung collectin, markedly accumulates during P. carinii pneumonia and binds to glycoprotein A (gpA) on the surface of P. carinii, thereby enhancing interactions with alveolar macrophages. Herein, we report the structural basis of the interaction of SP-D with gpA. We demonstrate that natural SP-D binds to purified gpA in the presence of 2 mM calcium in a saturable, concentration-dependent manner, which is abolished by 10 mM ethylenediaminetetraacetic acid. Increasing concentrations of calcium under otherwise cation-free conditions significantly enhance SP-D binding to gpA, whereas manganese and magnesium cations have minimal effect. Maximal SP-D binding occurs at pH 7.4, with significant inhibition at pH 4. SP-D binding to gpA is also competitively inhibited by maltose > glucose > mannose > N-acetyl-glucosamine. Comparison of the binding of various natural and recombinant forms of SP-D to gpA reveals that the number of carbohydrate recognition domains (CRDs) in a given SP-D form determines the relative extent of binding to gpA. Maximal binding is observed with natural SP-D (dodecamers and higher order SP-D complexes) followed by recombinant dodecamers. In contrast, recombinant full-length trimers exhibit substantially less binding, which is similar to that observed with a recombinant truncated molecule consisting of the CRD and neck regions, and containing trimers of this portion of the molecule. Taken together, these findings strongly indicate that the CRD of SP-D mediates interaction with P. carinii gpA through its attached oligosaccharides and that the extent of SP-D binding to P. carinii is greatest with dodecamers and higher order forms of SP-D.